B cells in TSK/+ mice that resemble human SSc symptoms showed lower stimulation thresholds with constitutive phosphorylation of CD19, increased Ca2+ release upon anti-CD19 activation, and enhanced IL-6 and IgG productions. This evidence concerns the gene TSKU and systemic sclerosis.